Challenges in prophylactic therapy with Emicizumab in patients with hemophilia A: Focus on monitoring tests
This study presents a transversal investigation that we performed at Fundeni hospital (Bucharest, Romania) into the therapeutic benefits and efficacy of Emicizumab, a non-factor therapy, in the context of hemophilia A. Ten patients diagnosed with hemophilia A were closely monitored using clinical an...
| الحاوية / القاعدة: | Romanian Journal of Laboratory Medicine |
|---|---|
| المؤلفون الرئيسيون: | , , , , , |
| التنسيق: | مقال |
| اللغة: | الإنجليزية |
| منشور في: |
Sciendo
2024-01-01
|
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.2478/rrlm-2024-0003 |